Bayesian Capital Management’s Livent Corporation LTHM Stock Holding History

Bayesian Capital Management’s Portfolio LTHM Stock Details LTHM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-16,200	Closed	-$291K	–	1197
2023 Q4	$291K	Sell	16,200 -500	-3%	-$7.79K	0.03%	519
2023 Q3	$307K	Sell	16,700 -61,300	-79%	-$1.4M	0.04%	466
2023 Q2	$2.14M	Buy	78,000 +6,500	+9%	+$156K	0.23%	114
2023 Q1	$1.55M	Buy	+71,500	New	+$1.65M	0.19%	155
2022 Q3	–	Sell	-39,682	Closed	-$900K	–	1084
2022 Q2	$900K	Buy	+39,682	New	+$1.02M	0.17%	181

Other funds holding LTHM

MIM

MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

WAM

Westport Asset Management Southport, Connecticut $226M AUM 16.76% 1-Year Est. Return

MLICM

Metropolitan Life Insurance Company (MetLife) New York $328M AUM 9.77% 1-Year Est. Return

AAG

Armstrong Advisory Group Needham, Massachusetts $1.64B AUM 19.37% 1-Year Est. Return

RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return

ACA

American Capital Advisory Ketchum, Idaho $248M AUM 21.64% 1-Year Est. Return

Bayesian Capital Management's LTHM Position: Q1 2024 in Review

Bayesian Capital Management sold out of Livent Corporation (LTHM) in Q1 2024, closing a stake of 16,200 shares — an estimated $291K sold.

Bayesian Capital Management first reported a position in LTHM in Q2 2022 and held it in 5 quarters. The position peaked at $2.14M in Q2 2023. 6 funds tracked by Wall St. Rank hold LTHM as of Q1 2024.

Bayesian Capital Management reported no remaining Livent Corporation position as of Q1 2024 after selling out during the quarter.
Bayesian Capital Management sold 16,200 Livent Corporation shares in Q1 2024, an estimated $291K.
Bayesian Capital Management first reported a position in Livent Corporation in Q2 2022 and held it in 5 quarters.
Bayesian Capital Management's Livent Corporation position peaked at $2.14M in Q2 2023.
6 funds tracked by Wall St. Rank held Livent Corporation as of Q1 2024.

Based on Bayesian Capital Management's 13F filing for Q1 2024, filed 15 May 2024.